Phase II: Study of ATL146e in Patients Undergoing Primary Coronary Stenting

$0R44FY2005HLNIH

Adenosine Therapeutics, Llc, Charlottesville VA

Investigators

Shannon P Williams

View original record on NIH RePORTER →